Rigel Pharmaceuticals (RIGL) Capital Expenditures (2010 - 2025)
Rigel Pharmaceuticals (RIGL) recorded quarterly Capital Expenditures of -$12000.0 in Q4 2025, down 146.15% quarter-over-quarter from $26000.0 in Q4 2024, and down 146.15% on a YoY basis from $26000.0 in Q4 2024.
Rigel Pharmaceuticals (RIGL) Capital Expenditures (2010 - 2025) Analysis & Trends
Rigel Pharmaceuticals' Capital Expenditures history runs 15 years deep, the most recent figure standing at -$12000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures fell 146.15% year-over-year to -$12000.0; the TTM figure through Dec 2025 stood at $276000.0 (up 9.52% YoY), while the FY2024 annual figure was $36000.0, changed N/A from the prior year.
- Capital Expenditures was -$12000.0 for Q4 2025 at Rigel Pharmaceuticals, down from $26000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $407000.0 in Q2 2021 to a low of -$36000.0 in Q2 2022.
- Historically, Capital Expenditures has averaged $109100.0 across 4 years, with a median of $72000.0 in 2021.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures soared 1025.0% in 2021, then plunged 146.15% in 2025.
- A 4-year view of Capital Expenditures shows it stood at -$21000.0 in 2021, then surged by 447.62% to $73000.0 in 2022, then plunged by 64.38% to $26000.0 in 2024, then sank by 146.15% to -$12000.0 in 2025.
- The last three Capital Expenditures figures came in at -$12000.0 (Q4 2025), $26000.0 (Q4 2024), and $73000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Dec 31, 2021 | -21,000.00 |
| Dec 31, 2021 | -21,000.00 |
| Sep 30, 2021 | 170,000.00 |
| Sep 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 407,000.00 |
| Jun 30, 2021 | 407,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Mar 31, 2021 | 71,000.00 |